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Solitary fibrous tumor (SFT) is a soft tissue tumor most frequently localized in the 
pleura, but it has recently been described in other body sites.  We have encountered a 
rare patient with an SFT of the buccal mucosa.  We examined the case clinically, histo-
pathologically and immunohistochemically.  Dimension of the resected tumor was 3 by 
2.5 by 3 cm. Histological observation revealed that the tumor was composed of spindle- 
or ovoid-shaped cells with varying amounts of haphazardly arranged collagen bundles. 
Immunohistochemically, the tumor cells exhibited strong staining with CD34 and bcl-2 
but were negative to smooth muscle actin, ckit and S-100 protein.  The patient was dis-
charged 7 days after surgery, with no signs of recurrences after 14 months.  We reported 
a rare case of buccal SFT and reviewed 38 cases of intraoral SFT. 
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Solitary fibrous tumor (SFT) is a rare neoplasm 
composed of spindle cells which Klemperer and 
Rabin (1931) first described in the pleura.  In early 
reports, SFT was thought to arise from the meso-
thelial cell and was once termed localized fibrous 
mesothelioma (England et al., 1989).  However, 
recent immunohistochemical, ultrastructural and 
tissue cultural studies have suggested that the ori-
gin of this tumor is the mesenchymal tissue (Dervan 
et al., 1986; Ali et al., 1997).  Thereafter, SFTs at 
almost every anatomic location have been reported 
(Goodlad et al., 1991), but very rarely in the oral 
cavity.  In the present paper, we present a case of 
SFT originating from the buccal mucosa.
 
Patient Report
 
In 2002, a 54-year-old man noticed a mass in the 
left buccal mucosa.  The mass had been asymp-
tomatic and had not increased in size.  In 2003, he 
visited a hospital for cytological examination of the 
mass, where its cytology was interpreted as benign. 
In March 2004, he was referred to our clinic for 
further examination of the mass.  
        Intraoral examination revealed a hard, elas-
tic  and nontender mobile mass which was about 3 
cm in size, 0overlayed by apparent normal buccal 
mucosa in its color and texture (Fig. 1).  There was 
neither swelling of the cervical lymph-nodes nor 
any significant change in laboratory data.  Magnetic 
resonance imaging (MRI) revealed that the lesion 
was a well-circumscribed, solid mass measuring 
Abbreviations: MRI, magnetic resonance imaging; SFT, 
solitary fibrous tumor; SMA, smooth muscle actin; 
GIST, gastrointestinal stromal tumor  
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about 3 cm in the right posterior buccal space.  The 
mass showed a signal intensity homogeneous with 
that of the muscle on both T1- and T2-weighted 
images (Fig. 2). Surgical extirpation was performed 
under general anesthesia in April 2004.  The tumor 
surface was smooth and clearly defined and was 
easily dissected from the surrounding tissue.  The 
tumor was oval-shaped, and measured 3 by 2.5 by 
3 cm.  The cut surface of the tumor was solid, firm, 
grayish-white and homogeneous (Fig. 3). 
        Histologically, the tumor was well-circum-
scribed and encapsulated with thin fibrous tissues. 
The lesion was composed of spindle- or ovoid-
shaped cells with a various amount of collagen 
bundles haphazardly arranged.  The tumor showed 
a partially slight storiform pattern appearance (Fig. 
4) and was vascularized, occasionally contained 
areas of dilated vessels with a stag-horn appear-
ance sometimes seen in hemangiopericytoma (Fig. 
5).  The mitotic count was 0/10 high-power-field. 
There was no necrosis.
        Through immunohistochemical studies on 
paraffin-embedded tissue sections, the tumor cells 
were strongly positive to CD34 and bcl-2, but 
negative to smooth muscle actin (SMA), c-kit and 
S-100 protein (Fig. 6).  These findings resulted in a 
diagnosis of SFT.
        After surgery, the patient improved progres-
sively and was discharged with no difficulty.  Since 
Fig. 1.  An elastic hard mobile mass about 3 cm in size 
could be palpated intraorally. 
Fig. 2.  MRI shows a well-circumscribed mass about 
3 cm in diameter.  The mass shows a signal intensity 
homogeneous to that of the muscle on both T1- and T2-
weighted images.
 
Fig. 3.  The cut surface of the tumor is solid, firm, gray-
ish-white and homogeneous. 
 
then, the patient was followed-up for 1 year in the 
outpatient clinicand has showed no signs of recur-
rence as of this writing. 
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Fig. 4.  The tumor shows a partially storiform pattern 
appearance (hematoxylin and eosin stain).  Bar =100 µm. 
Fig. 5.  The SFT tumor is vascularized and partially 
contains areas of dilated vessels with a stag-horn ap-
pearance also occasionally seen in hemangiopericytoma 
(hematoxylin and eosin stain).  Bar = 160 µm. 
Discussion
 
Current advances in immunohistochemical, ul-
trastructural and tissue cultural techniques have 
greatly contributed to studies on SFTs.  Since 
Gunhan (1994) first described SFT in the oral cav-
ity, many intraoral SFTs were found and 38 patients 
were reported in the literature, all of it in English 
(Gunhan et al., 1994; Suster et al., 1995; Piatteli et 
al., 1998; Iwai et al., 1999; Kurihara et al., 1999; 
Perez-Ordonez et al., 1999; Brunnemann et al., 
1999; Lukinmaa et al., 2000; Alawi et al., 2001; 
Hirano et ai., 2001; Kuo et al., 2001; Shin et al., 
2001; Harada et al., 2002; Hardisson et al., 2002; 
Vargas et al., 2002; Shnayder et al., 2003; Yana-
moto et al., 2003).  The clinicopathological features 
of these oral SFT patients including the present 
one are summarized in Table 1 with no significant 
sex predilection (21 females, 18 males).  SFTs 
develop in adulthood over a wide age range, and 
most are identified between 40s and 70s (mean 51.3 
years) with tumor sizes varing 8 to 45 mm (mean 
21.5 mm).  Patients with pleural large SFTs have 
symptoms such as chronic cough, short of breath, 
osteoarthropathy, chest pain and hypoglycemia 
(Weiss et al., 2001).  In the present series of studies 
(Table 1), no such symptoms have been identified 
in patients with intraoral SFT except one.  This ex-
ception was a female patient with malignant SFT of 
the tongue, and actually had a history of dysarthria 
and dysphagia (Shnayder et al., 2003).  She was 
the only case of malignant SFT of the oral cav-
ity, with a 25-year history of an apparently stable 
tongue mass.  However, the mass increased in size, 
and her symptoms were aggravated for 6 months 
before admission.  Therefore, we should suspect 
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malignant transformation of SFT for patients with a 
long clinical history.  Concerning the incidence of 
SFT in the oral cavity, the buccal mucosa or cheek 
shows higher levels, followed by the tongue. 
        MRI images of SFT for this patient showed a 
signal intensity homogeneous to that of the muscle 
on both T1- and T2-weighted images.  Likewise, 
Sato et al. (1998) reported that low signal levels 
on both T1- and T2-weighted images would be 
characteristic of SFT.  However, even though some 
reports showed low levels on T1-weighted images, 
high levels on T2-weighted images were also seen 
(Yanamoto et al., 2003).  We think that the histo-
logical diversity of SFT leads to the difference in 
MRI findings. 
Fig. 6.  This SFT tumor shows diffuse and strong im-
munoreactivity for CD34 (A) and bcl-2 (B) but is nega-
tive to SMT (C), S100 protein (D) and c-kit (E).  Bar = 
100 µm.
        Generally, diagnosing SFT is difficult because 
of its broad range of morphologic characteristics, 
including storiform, hemangiopericytic, her-
ringbone and palisading areas (Chan, 1997).  In 
the present case, we observed a storiform pattern 
along with a stag-horn appearance occasionally 
seen in hemangiopericytoma.  Therefore, the cur-
rent diagnosis of SFT has been based on histologi-
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Table 1.  Clinical and pathologic features of 39 patients with intraoral SFT
Num-        Report Age Sex Location Size Clin- 
 ber  (yr)   (mm) ical 
      history
 1 Gunhan et al. 1994 55 M Sublingual 
     gland 30 12 yr NA + NA NA – – NA NA NA
 2 Suster et al. 1995 50 F Soft palate 40   NA + + NA NA – – NA – NA
 3 Suster et al. 1995 83 M Cheek 15   NA + + NA NA – – NA – NA
 4 Piatteli et al.  1998 66 F Tongue 10   1 yr + + + NA NA – – – NA
 5 Iwai et al.   1999 27 M Buccal mucosa 20   5 yr + + NA NA NA – NA NA NA
 6 Kurihara et al. 1999 34 F Buccal mucosa 15   3 yr + + NA – – – – – NA
 7 Perez-Ordonez et al. 1999 39 F Mandible 10   1 mo + + + NA – – NA NA NA
 8 Perez-Ordonez et al. 1999 70 M Buccal mucosa 40   NA + + – NA – – NA NA NA
 9 Brunnemann et al.  1999 46 F Buccal mucosa 29   NA NA NA NA NA NA NA NA NA NA
10 Brunnemann et al. 1999 53 M Oral mucosa 22   NA NA NA NA NA NA NA NA NA NA
11 Lukinmaa et al.  2000 56 M Cheek 20 10 yr + + + – NA – – NA NA
12 Lukinmaa et al.  2000 45 F Cheek 15   6 mo + + + – NA – – NA NA
13 Lukinmaa et al.  2000 70 M Cheek 10   6 mo + + + – NA – – NA NA
14 Hirano et al. 2001 64 F Mental 32   9 yr + + NA + – – NA NA –
15 Kuo et al.  2001  31 M Infraorbital 40   4 yr + + + – NA – – NA NA
16 Alawi et al.  2001 44 F Tongue 11   NA +    NA   NA NA
17 Alawi et al.  2001 40 M Buccal mucosa 12   1 yr +    NA   NA NA
18 Alawi et al.  2001 55 M Buccal mucosa 33   3 yr +    NA   NA NA
19 Alawi et al.  2001 51 F Buccal mucosa 40   3 yr +    NA   NA NA
20 Alawi et al. 2001 38 F Buccal mucosa 14   NA +    NA   NA NA
21 Alawi et al. 2001 31 F Buccal mucosa 30   2 yr +    NA   NA NA
22 Alawi et al.  2001 61 M Buccal mucosa 33   2.5 yr +    NA   NA NA
23 Alawi et al.  2001 63 M Buccal mucosa  9   NA +    NA   NA NA
24 Alawi et al. 2001 60 F Buccal mucosa  8 15 yr +    NA   NA NA
25 Alawi et al. 2001 58 F Buccal mucosa  8   NA +    NA   NA NA
26 Alawi et al. 2001 64 F Lower Lip 13 11 mo +    NA   NA NA
27 Alawi et al. 2001 67 F Buccal mucosa 12   NA +    NA   NA NA
28 Alawi et al.  2001 60 M Buccal mucosa 17   NA +    NA   NA NA
29 Alawi et al.  2001 73 F Buccal mucosa 13 50 yr +    NA   NA NA
30 Alawi et al.  2001 48 F Tongue 8   8 mo +    NA   NA NA
31 Alawi et al.  2001 36 M Lower Lip 8   4 mo +    NA   NA NA
32 Shin et al.  2001 46 M Buccal mucosa 27   1 mo + + NA NA – – – NA NA
33 Harada et al.  2002 32 M Gingival  10   5 yr + + NA – – – NA NA NA
34 Hardisson et al.  2002 56 F Cheek 15   2 yr + + + NA – – NA – NA
35 Vargas et al.  2002 20 F Cheek 30   6 mo + + + – – – – NA NA
36 Vargas et al.  2002 65 F Tongue 48 15 yr + + + – – – – NA NA
37* Shnayder et al.  2003 57 F Tongue 25 25 yr + + + – – – – NA –
38 Yamamoto et al.  2003 32 M Buccal mucosa 35   1 yr + + + – – – – – NA
39 Tanio et al.  Present 56 M Buccal mucosa 30 24 mo + NA + – NA – NA NA –
* Case 37 was the only malignant tumor in this series.
† Positive case(s)/examined cases reported in Alawi et al. (2001).
 F, female; M, male; mo, month(s); NA, not available; SFT, solitary fibrous tumor; SMA, smooth muscle actin; yr, 
year(s). 
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cal and immunohistochemical findings.  In 1997, 
Chan proposed an immunohistochemical profile in 
which SFT is immunopositive to vimentin, CD34 
and bcl-2, but is negative to cytokeratin, von Wil-
lebrand factor, SMA and S-100 protein.  In 56 
pleural and extrapleural SFTs, Suster et al. (1998) 
showed a close correlation between the expressions 
of CD34 and bcl-2.  The present case and other 
cases shown in Table 1 were positive to CD34 and 
bcl-2.  Although many reports have emphasized 
the importance of CD34 in diagnosis of SFT, CD34 
immunopositivity is not specific to SFT.  Tumors 
including hemangiopericytoma, neurofibroma, 
neurilemmoma, angioleiomyoma, gastrointestinal 
stromal tumor (GIST) and dermatofibrosarcoma 
protuberans are positive to CD34.  Neurofibroma 
and neurilemmoma are usually positive to S-100 
protein, whereas SFT is negative.  Dermatofibro-
sarcoma protuberans is rarely involved in oral soft 
tissues, but it can be distinguished from SFT by 
its malignant cytologic features.  Also, angioleio-
myoma is positive to SMA, where SFT is usually 
negative. GIST is positive to c-kit.  Hemangioperi-
cytoma is probably the most difficult to be distin-
guished from SFT, because SFT often presents 
hemangiopericytoma-like areas.  Hemangiopericy-
toma also has immunoactivity for CD34 like SFT. 
However, hemangio-pericytoma lacks the other 
morphologic features associated with SFT, such as 
the storiform pattern, herringbone pattern, neural 
palisades and thick collagenous stroma.  These 
facts convinced us that we should differentiate this 
case as SFT. 
        Diagnosis of SFT is difficult and, although un-
common, it should be contained in the differential 
diagnosis of oral soft tissue tumors.  We reported a 
rare case of SFT and reviewed 38 cases of intraoral 
SFT.
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